SEM

Select Medical Holdings Corporation

Connor Clark & Lunn Investment Management Ltd. purchased a new position in Select Medical Holdings Corporation (NYSE:SEM - Free Report) during the second quarter, according to the company in its most...

Select Medical Holdings Corporation (NYSE:SEM - Free Report) - Analysts at Zacks Research cut their Q4 2025 earnings estimates for Select Medical in a research report issued on Thursday, November...

Campbell & CO Investment Adviser LLC increased its position in shares of Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 256.8% during the 2nd quarter, according to the company in its...

SEM's Q3 earnings drop 11.5% year over year due to the rising cost of services, despite a revenue beat and raised 2025 EPS guidance.

Wall Street Zen upgraded shares of Select Medical from a "hold" rating to a "buy" rating in a report on Saturday...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Select Medical (SEM) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

The consensus price target hints at a 35.9% upside potential for Select Medical (SEM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.